Java 27 is now available, enabling G1 as the default garbage collector everywhere and bringing Compact Object Headers, TLS ...

The first bellwether case scheduled to be tried in the Generic Pharmaceuticals Pricing antitrust litigation has been postponed after Mylan objected to an “apparent conflict of interest” involving the ...

If you take a patented, brand-name medication — a cancer biologic, an autoimmune drug, a specialty injection — the supply chain behind that drug is about to be permanently restructured, starting at 12 ...

Par Health has launched the first generic formulation of Janumet XR in 3 extended-release dosage strengths, offering a lower-cost alternative for glycemic control. Par Health announced the ...

Imported generic drugs could face tariffs of up to 100% beginning in 2028 under a plan announced Tuesday by President Trump, who said the measure is intended to push manufacturers to move production ...

The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...

In a social media post, President Trump said the goal of the newly proposed generics duties is to apply a penalty to companies “that decide not to build Plant and Equipment within the stated period of ...

President Donald Trump announced Tuesday that imported generic drugs will remain tariff-free for the next two years before facing steep new import duties, saying the move is designed to encourage ...

President Donald Trump on Tuesday announced a plan to impose a 100 percent tariff on generic drugs starting in August 2028 as part of a bid to push pharmaceutical production back to the United States.

A multiyear “tariff cliff” sets 0% through July 2028, then 100% for one year and 200% thereafter, explicitly tying penalties to failure to establish US manufacturing capacity. Sparse implementation ...

The administration has repeatedly said it will impose steep pharmaceutical tariffs but has not followed through on them. By Rebecca Robbins President Trump said on Tuesday evening that he planned to ...

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s ...